On Demand Webinars
ICH Q3E Guidelines and Its Implications
Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Dries Cardoen, Team Leader of Study Directors Inhalation/topical/transdermal products at Nelson Laboratories, LLC
22nd March 2021
Hybrid Models: The Best of Both (Mechanistic & Empirical) Worlds to Accelerate and De-Risk Process Development
Presented by Christian Airiau, PhD, Global Head Data Sciences, Biologics Development at Sanofi and Chris McCready, Lead Data Scientist at Sartorius Stedim Biotech
16th March 2021
Development and Implementation of Intensified Bioprocessing for Biologics Manufacturing
Presented by Hang Zhou, Ph.D., Vice President, Head of Cell Culture Process Development Biologics and Bioprocess Dept. at WuXi Biologics
12th March 2021
Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted
Presented by Christos Varsakelis PhD, Team Lead Artificial Intelligence/Machine Learning Compound Profiling at The Janssen Pharmaceutical Companies of Johnson & Johnson, Mark Demesmaeker, Head of Data Analytics at Sartorius Stedim Biotech and Roger-Marc Nicoud, President & CEO Ypso-Facto
10th March 2021
Demonstrate how machine learning tools can aid development of formulation, analysis and manufacturing of pharmaceutical drug products
Presented by Erik Skibsted, Principal Scientist PhD, Novo Nordisk Denmark and Rolf Taaning, Development Specialist PhD, Novo Nordisk Denmark
08th March 2021
A Data Driven Biopharmaceutical Manufacturing Facility-Plug and Produce -Shaping the Future Together
Presented by Josef Trapl Global Manufacturing & Supply, Head of MSci Innovation at Takeda and Petter Moree, Global Industry Principal at OSIsoft
04th March 2021
Improving Efficiency in Upstream Process Development
Presented by Jackie Gonzalez, Senior Upstream Development Engineer at Takeda, Klaus Mauch, CEO at Insilico Biotechnology AG
01st March 2021
Operational Excellence in Process Development in Drug Substance Production
Presented by Ken Green, Ph.D, Head of Manufacturing, Science and Technology at Samsung Biologics, Klaus Mauch, CEO at Insilico Biotechnology AG
11th February 2021
Future Trends To Control Risks From Extractables and Leachables
Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Kathleen Lava PhD – E&L Expert Nelson Labs Europe
09th February 2021
Changing the Paradigm: Moving to In-Process Release Testing
Presented by Presented by Scott Weiss, Director, Industrial Microbiology at Johnson & Johnson and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
05th February 2021
